Last Close
Apr 08  •  04:00PM ET
75.53
Dollar change
+1.68
Percentage change
2.27
%
Today, 7:05 AMHenry Schein Chairman Stanley M. Bergman to retire from board, become Chairman Emeritus
Index
S&P 500
P/E
23.10
EPS (ttm)
3.27
Insider Own
14.87%
Shs Outstand
115.77M
Perf Week
2.48%
Market Cap
8.66B
Forward P/E
12.86
EPS next Y
5.88
Insider Trans
-0.62%
Shs Float
97.64M
Perf Month
-3.29%
Enterprise Value
13.49B
PEG
1.41
EPS next Q
1.21
Inst Own
93.11%
Perf Quarter
-3.84%
Income
398.00M
P/S
0.66
EPS this Y
7.06%
Inst Trans
-6.30%
Perf Half Y
14.37%
Sales
13.18B
P/B
2.69
EPS next Y
10.42%
ROA
3.71%
Perf YTD
-0.07%
Book/sh
28.03
P/C
55.54
EPS next 5Y
9.11%
ROE
11.99%
52W High
89.29 -15.41%
Perf Year
20.46%
Cash/sh
1.36
P/FCF
15.12
EPS past 3/5Y
-5.75% 3.12%
ROIC
6.85%
52W Low
60.56 24.72%
Perf 3Y
-10.86%
Dividend Est.
-
EV/EBITDA
12.24
Sales past 3/5Y
1.40% 5.43%
Gross Margin
29.14%
Volatility
2.83% 2.64%
Perf 5Y
9.99%
Dividend TTM
-
EV/Sales
1.02
EPS Y/Y TTM
7.11%
Oper. Margin
6.00%
ATR (14)
2.14
Perf 10Y
14.71%
Dividend Ex-Date
-
Quick Ratio
0.76
Sales Y/Y TTM
4.03%
Profit Margin
3.02%
RSI (14)
51.64
Dividend Gr. 3/5Y
- -
Current Ratio
1.38
EPS Q/Q
14.07%
SMA20
2.01%
Beta
0.88
Payout
0.00%
Debt/Eq
1.06
Sales Q/Q
7.71%
SMA50
-1.60%
Rel Volume
1.11
Prev Close
73.85
Employees
25000
LT Debt/Eq
0.79
SMA200
4.52%
Avg Volume
1.36M
Price
75.53
IPO
Nov 03, 1995
Option/Short
Yes / Yes
Trades
Volume
1,509,365
Change
2.27%
Date Action Analyst Rating Change Price Target Change
Feb-23-26Upgrade Robert W. Baird Neutral → Outperform $100
Dec-09-25Initiated Barclays Overweight $86
Aug-26-25Upgrade Evercore ISI In-line → Outperform $83
Jul-25-25Downgrade Stifel Buy → Hold $75
Jul-14-25Downgrade Robert W. Baird Outperform → Neutral $72
Feb-14-25Initiated Wells Fargo Equal Weight $80
Jan-06-25Upgrade BofA Securities Underperform → Buy $69 → $84
Dec-04-24Initiated Mizuho Neutral $75
Jul-22-24Upgrade Robert W. Baird Neutral → Outperform $81 → $92
Feb-26-24Initiated Leerink Partners Market Perform $78
Today 07:00AM
Apr-07-26 03:08PM
Mar-30-26 03:22AM
Mar-18-26 06:30AM
Mar-10-26 06:30AM
09:40AM Loading…
Mar-05-26 09:40AM
Mar-03-26 06:30AM
Mar-02-26 09:45AM
Feb-24-26 03:10PM
02:03PM
01:55PM
12:32PM
11:47AM
11:10AM
09:59AM
09:30AM Loading…
09:30AM
08:46AM
07:54AM
07:35AM
06:17AM
06:00AM
Feb-23-26 09:32AM
Feb-22-26 10:09PM
Feb-19-26 10:00AM
06:30AM
Feb-17-26 10:00AM
09:19AM
06:30AM
Feb-16-26 10:39AM
Feb-06-26 06:30AM
06:30AM Loading…
Jan-22-26 06:30AM
Jan-20-26 09:47AM
Jan-15-26 10:00AM
Jan-14-26 11:06PM
01:27PM
Jan-13-26 09:40AM
Jan-12-26 11:15AM
09:57AM
07:00AM
Jan-06-26 11:40AM
Jan-05-26 12:37AM
Dec-29-25 06:30AM
Dec-26-25 09:50AM
Dec-23-25 04:05PM
Dec-18-25 07:54AM
Dec-09-25 04:00PM
02:37PM
Dec-04-25 11:30AM
Dec-03-25 10:31PM
Dec-02-25 08:25AM
Dec-01-25 04:34PM
07:52AM
Nov-25-25 06:30AM
Nov-13-25 09:40AM
06:30AM
Nov-12-25 07:00AM
Nov-11-25 08:26AM
Nov-07-25 09:50AM
Nov-06-25 10:21PM
09:45AM
08:00AM
Nov-04-25 04:00PM
09:30AM
08:54AM
07:10AM
06:36AM
06:10AM
06:00AM
Nov-03-25 06:30AM
Nov-02-25 10:13PM
Oct-29-25 10:00AM
Oct-28-25 10:00AM
Oct-23-25 08:07AM
Oct-22-25 06:30AM
Oct-21-25 07:28AM
06:30AM
Oct-15-25 10:30AM
Oct-08-25 12:02AM
Sep-25-25 01:07PM
07:22AM
Sep-17-25 01:15PM
Sep-16-25 09:32AM
Sep-11-25 08:31AM
Sep-09-25 05:10PM
10:18AM
Aug-28-25 11:31PM
Aug-22-25 06:30AM
Aug-21-25 11:39AM
Aug-19-25 06:30AM
Aug-13-25 12:15AM
12:07AM
Aug-05-25 12:41PM
10:16AM
09:30AM
09:05AM
07:10AM
06:50AM
06:07AM
06:00AM
Aug-03-25 11:17PM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Popeck Thomas CCEO, Henry Schein ProductsMar 19 '26Sale72.791,35598,63086,182Mar 20 04:07 PM
Popeck Thomas COfficerMar 19 '26Proposed Sale72.791,35598,630Mar 19 12:30 PM
KUEHN KURT PDirectorMar 10 '26Sale78.962,844224,56515,420Mar 11 04:08 PM
KUEHN KURT PDirectorMar 10 '26Proposed Sale78.962,844224,565Mar 10 01:42 PM
MLOTEK MARK EEVP, Chief Strategic OfficerMar 04 '26Sale80.805,925478,74080,554Mar 06 06:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Sale80.362,844228,54421,961Mar 06 05:08 PM
LASKAWY PHILIP ADirectorMar 05 '26Proposed Sale80.362,844228,544Mar 05 12:40 PM
MLOTEK MARK EOfficerMar 04 '26Proposed Sale80.805,925478,739Mar 04 04:28 PM
BERGMAN STANLEY MChairman, CEOMar 02 '26Sale81.3143,8123,562,354383,803Mar 03 08:18 AM
Stanley M. BergmanCEO, ChairmanMar 02 '26Proposed Sale82.3943,8123,609,671Mar 02 06:31 PM
BERGMAN STANLEY MChairman, CEOFeb 26 '26Sale81.0138,3463,106,591427,615Feb 27 04:31 PM
BERGMAN STANLEY MChairman, CEOFeb 27 '26Sale81.2010,785875,742309,092Feb 27 04:31 PM
Stanley M. BergmanCEO, ChairmanFeb 27 '26Proposed Sale81.4710,785878,654Feb 27 04:22 PM
Stanley M. BergmanOfficerFeb 26 '26Proposed Sale81.9143,0463,525,898Feb 26 04:25 PM
Siegel WalterOfficerNov 17 '25Proposed Sale71.304,176297,749Nov 17 10:29 AM
DANIEL WILLIAM KDirectorAug 07 '25Buy67.0810,000670,80010,000Aug 11 04:26 PM